Disruption of insulin receptor substrate 2 (IRS2) causes non-obese type 2 diabetes with β-cell dysfunction in the golden (Syrian) hamster

Sci Rep. 2024 Aug 12;14(1):17450. doi: 10.1038/s41598-024-67513-9.

Abstract

Because of the advent of genome-editing technology, gene knockout (KO) hamsters have become attractive research models for diverse diseases in humans. This study established a new KO model of diabetes by disrupting the insulin receptor substrate-2 (Irs2) gene in the golden (Syrian) hamster. Homozygous KO animals were born alive but with delayed postnatal growth until adulthood. They showed hyperglycemia, high HbA1c, and impaired glucose tolerance. However, they normally responded to insulin stimulation, unlike Irs2 KO mice, an obese type 2 diabetes (T2D) model. Consistent with this, Irs2 KO hamsters did not increase serum insulin levels upon glucose administration and showed β-cell hypoplasia in their pancreas. Thus, our Irs2 KO hamster provide a unique T2D animal model that is distinct from the obese T2D models. This model may contribute to a better understanding of the pathophysiology of human non-obese T2D with β-cell dysfunction, the most common type of T2D in East Asian countries, including Japan.

Keywords: Animal model; Glucose metabolism; Insulin; Pancreas; Type 2 diabetes mellitus.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cricetinae
  • Diabetes Mellitus, Type 2* / genetics
  • Diabetes Mellitus, Type 2* / metabolism
  • Disease Models, Animal
  • Gene Knockout Techniques
  • Humans
  • Insulin / metabolism
  • Insulin Receptor Substrate Proteins* / genetics
  • Insulin Receptor Substrate Proteins* / metabolism
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Male
  • Mesocricetus*

Substances

  • Blood Glucose
  • Insulin
  • Insulin Receptor Substrate Proteins